[Variabilidad del patrón de sensibilidad alérgica en adultos mayores].

Objective: Describe the pattern of allergic sensitivity in elderly.

Methods: Elderly (>60 years old) with a diagnosis of allergic respiratory disease in whom sensitivity was identified by pricking with ALK-abello extracts (Port Washington, NY, United States) were included. The results were analyzed using descriptive statistics and compared with a series of young adults in a 3:1 ratio.

Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future.

The discovery of the mechanism underlying allergic disease, mouse models of asthma, and bronchoscopy studies provided initial insights into the role of Th2-type cytokines, including interlukin (IL)-4, IL-5 and IL-13, which became the target of monoclonal antibody therapy. Omalizumab, Benralizumab, Mepolizumab, Reslizumab, and Tezepelumab have been approved. These biologicals have been shown to be good alternative therapies to corticosteroids, particularly in severe asthma management, where they can improve the quality of life of many patients.